• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产碳青霉烯酶肠杆菌科细菌的爆发:COVID-19 的另一个阴暗面。

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19.

机构信息

Service de Biologie Clinique, Hôpital Foch, Suresnes, France.

Service de Biologie Clinique, Hôpital Foch, Suresnes, France.

出版信息

Am J Infect Control. 2020 Dec;48(12):1533-1536. doi: 10.1016/j.ajic.2020.09.015. Epub 2020 Oct 2.

DOI:10.1016/j.ajic.2020.09.015
PMID:33011336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7529666/
Abstract

In the hospital department dedicated to COVID-19-patient, infection prevention and control measures were upgraded. Therefore, the cross-transmission of other micro-organisms was thought unlikely to occur. However, we report an outbreak of NDM-5-producing Escherichia. coli in a 12-beds ICU dedicated to COVID-19 patients. This outbreak involved 6 patients of which 5 were asymptomatic carriers and 1 was infected. Several findings might have contributed to cross-transmission including the multiple-bedroom configuration of the department, uncomplete compliance for standard and contact precautions, overwork due to the burden of the disease, lack of training of staff for the care of ICU-patients, and misuse of gloves. Furthermore, as infection prevention and control measures were thought to be applied, contact patients were not screened for eXDR carriage. Applying rigorously standard and contact precautions and performing screening in contact patients when indicated must be the rules in COVID-19 wards.

摘要

在专门收治 COVID-19 患者的医院科室,感染预防和控制措施得到了升级。因此,其他微生物的交叉传播不太可能发生。然而,我们报告了一起在专门收治 COVID-19 患者的 12 张病床 ICU 中发生的产 NDM-5 型大肠埃希菌的暴发。该暴发涉及 6 名患者,其中 5 名无症状携带者,1 名感染者。多个因素可能导致了交叉传播,包括科室的多床位配置、标准和接触预防措施的不完全遵守、由于疾病负担导致的过度劳累、对 ICU 患者护理人员的培训不足以及手套的误用。此外,由于感染预防和控制措施被认为已经得到应用,接触患者并未进行 XDR 携带筛查。在 COVID-19 病房中,严格遵守标准和接触预防措施,并在需要时对接触患者进行筛查,必须成为规定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6274/7529666/f78b6103f970/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6274/7529666/a1bf1b976004/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6274/7529666/f78b6103f970/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6274/7529666/a1bf1b976004/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6274/7529666/f78b6103f970/gr2_lrg.jpg

相似文献

1
Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19.产碳青霉烯酶肠杆菌科细菌的爆发:COVID-19 的另一个阴暗面。
Am J Infect Control. 2020 Dec;48(12):1533-1536. doi: 10.1016/j.ajic.2020.09.015. Epub 2020 Oct 2.
2
Nosocomial cluster of carbapenemase-producing Enterobacter cloacae in an intensive care unit dedicated COVID-19.COVID-19 定点医院 ICU 中产碳青霉烯酶阴沟肠杆菌的医院感染聚集性事件。
Antimicrob Resist Infect Control. 2021 Oct 21;10(1):151. doi: 10.1186/s13756-021-01022-6.
3
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.SARS-CoV-2 预防措施对 ESKAPE 和大肠杆菌感染的保护作用。
Eur J Clin Invest. 2021 Dec;51(12):e13687. doi: 10.1111/eci.13687. Epub 2021 Oct 11.
4
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.集束化防控策略是控制产碳青霉烯酶肠杆菌科爆发的唯一方法吗?一项单中心经验。
J Hosp Infect. 2018 Aug;99(4):390-395. doi: 10.1016/j.jhin.2018.02.003. Epub 2018 Feb 10.
5
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.某大学医院 ICU 和 HSCT 病房高危患者中产碳青霉烯酶肠杆菌科直肠定植的流行病学和危险因素。
Antimicrob Resist Infect Control. 2020 Sep 23;9(1):155. doi: 10.1186/s13756-020-00816-4.
6
Outbreak of carbapenemase-producing Enterobacteriaceae associated with a contaminated water dispenser and sink drains in the cardiology units of a Korean hospital.韩国一家医院心内科的带污染滤水器和水槽排水管的肠杆菌科碳青霉烯酶产生菌爆发。
J Hosp Infect. 2020 Apr;104(4):476-483. doi: 10.1016/j.jhin.2019.11.015. Epub 2019 Nov 27.
7
Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball.ICU 收治的 COVID-19 患者中耐碳青霉烯类肺炎克雷伯菌:密切关注。
J Glob Antimicrob Resist. 2020 Dec;23:398-400. doi: 10.1016/j.jgar.2020.11.004. Epub 2020 Nov 23.
8
Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.不同控制措施预防产碳青霉烯酶肠杆菌科和耐糖肽肠球菌爆发的效率:2010 年 1 月至 2015 年 12 月法国多医院机构的一项 6 年前瞻性研究。
Euro Surveill. 2018 Feb;23(8). doi: 10.2807/1560-7917.ES.2018.23.8.17-00078.
9
Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.产碳青霉烯酶肠杆菌科在高流行国家儿科医院的流行病学。
J Infect Public Health. 2019 Mar-Apr;12(2):270-274. doi: 10.1016/j.jiph.2018.11.003. Epub 2018 Nov 23.
10
Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.感染控制和获得产碳青霉烯酶肠杆菌科的危险因素。一项为期 5 年(2011-2016 年)的病例对照研究。
Antimicrob Resist Infect Control. 2020 Jan 17;9(1):18. doi: 10.1186/s13756-019-0668-2. eCollection 2020.

引用本文的文献

1
Colonization with antibiotic resistant bacteria in communities and hospitals across six countries, including Bangladesh, Botswana, Chile, Guatemala, India, and Kenya.包括孟加拉国、博茨瓦纳、智利、危地马拉、印度和肯尼亚在内的六个国家的社区和医院中存在对抗生素耐药细菌的定植情况。
Sci Rep. 2025 Jul 1;15(1):21275. doi: 10.1038/s41598-025-94750-3.
2
Trends in Healthcare-Acquired Infections Due to Multidrug-Resistant Organisms at a German University Medical Center Before and During the COVID-19 Pandemic.德国大学医学中心在新冠疫情之前及期间由多重耐药菌引起的医疗保健相关感染趋势
Microorganisms. 2025 Jan 25;13(2):274. doi: 10.3390/microorganisms13020274.
3

本文引用的文献

1
COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis.新冠病毒病:在停止特定感染预防与控制措施之前,务必排除诊断。
J Hosp Infect. 2020 Jun;105(2):375-376. doi: 10.1016/j.jhin.2020.04.021. Epub 2020 Apr 25.
2
Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.医护人员遵守呼吸道传染病感染预防与控制(IPC)指南的障碍与促进因素:一项快速定性证据综合分析
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD013582. doi: 10.1002/14651858.CD013582.
3
National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study.
阿根廷新冠疫情后时代产碳青霉烯酶肠杆菌科细菌流行情况的全国多中心研究:RECAPT-AR研究
Antibiotics (Basel). 2024 Nov 27;13(12):1139. doi: 10.3390/antibiotics13121139.
4
Profile of bacterial resistance in emergency wards, non-intensive care unit areas, and intensive care units in Mexican hospitals with the antimicrobial stewardship program.墨西哥医院实施抗菌药物管理计划后,急诊病房、非重症监护病房区域和重症监护病房的细菌耐药情况
IJID Reg. 2024 Oct 24;13:100474. doi: 10.1016/j.ijregi.2024.100474. eCollection 2024 Dec.
5
Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis.2019年冠状病毒病大流行和抗菌药物管理对医院感染中抗菌药物耐药性的多重影响:一项中断时间序列分析
Front Public Health. 2024 Jul 17;12:1419344. doi: 10.3389/fpubh.2024.1419344. eCollection 2024.
6
Impact of the coronavirus disease 2019 pandemic on the incidence of other infectious diseases in the hematology hospital in Korea.2019 年冠状病毒病大流行对韩国血液科医院其他传染病发病率的影响。
Korean J Intern Med. 2024 May;39(3):513-523. doi: 10.3904/kjim.2023.508. Epub 2024 Apr 23.
7
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world.合并感染与抗微生物药物耐药性与严重急性呼吸综合征冠状病毒2感染:新冠疫情后世界的困境。
Case Stud Chem Environ Eng. 2021 Jun;3:100093. doi: 10.1016/j.cscee.2021.100093. Epub 2021 Feb 21.
8
How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?新冠疫情如何影响巴西的抗菌药物消费和细菌耐药情况?
Antibiotics (Basel). 2023 Aug 28;12(9):1374. doi: 10.3390/antibiotics12091374.
9
Secondary bacterial infections & extensively drug-resistant bacteria among COVID-19 hospitalized patients at the University Hospital in Kraków.克拉科夫大学医院 COVID-19 住院患者中的继发性细菌感染和广泛耐药菌。
Ann Clin Microbiol Antimicrob. 2023 Aug 24;22(1):77. doi: 10.1186/s12941-023-00625-8.
10
Characterization of aminoglycoside resistance genes in multidrug-resistant Klebsiella pneumoniae collected from tertiary hospitals during the COVID-19 pandemic.在 COVID-19 大流行期间,从三级医院采集的多药耐药肺炎克雷伯菌中氨基糖苷类耐药基因的特征。
PLoS One. 2023 Jul 28;18(7):e0289359. doi: 10.1371/journal.pone.0289359. eCollection 2023.
Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland.
应对冠状病毒病(COVID-19)大流行导致的个人和防护设备(PPE)供应链严重短缺的挑战和解决方案-来自爱尔兰共和国的案例研究。
Sci Total Environ. 2020 Jul 10;725:138532. doi: 10.1016/j.scitotenv.2020.138532. Epub 2020 Apr 6.
4
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020.2020 年 1 月 1 日至 3 月 15 日期间,欧盟/欧洲经济区和英国的冠状病毒病(COVID-19)累计发病率迅速上升。
Euro Surveill. 2020 Mar;25(11). doi: 10.2807/1560-7917.ES.2020.25.11.2000285. Epub 2020 Mar 16.
5
Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.多种细菌中携带碳青霉烯酶基因(KPC)的危险因素及其临床结局。
J Hosp Infect. 2020 Apr;104(4):456-468. doi: 10.1016/j.jhin.2020.01.005. Epub 2020 Jan 10.
6
Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study.荷兰医院产超广谱β-内酰胺酶肠杆菌科患者的单人或多人病房中实施接触预防措施:一项集群随机、交叉、非劣效性研究。
Lancet Infect Dis. 2019 Oct;19(10):1069-1079. doi: 10.1016/S1473-3099(19)30262-2. Epub 2019 Aug 23.
7
Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria.氨曲南联合克拉维酸、他唑巴坦或阿维巴坦治疗产金属β-内酰胺酶革兰氏阴性菌感染。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00010-19. Print 2019 May.
8
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.集束化防控策略是控制产碳青霉烯酶肠杆菌科爆发的唯一方法吗?一项单中心经验。
J Hosp Infect. 2018 Aug;99(4):390-395. doi: 10.1016/j.jhin.2018.02.003. Epub 2018 Feb 10.
9
The misuse and overuse of non-sterile gloves: application of an audit tool to define the problem.非无菌手套的误用与过度使用:应用审核工具界定问题
J Infect Prev. 2015 Jan;16(1):24-31. doi: 10.1177/1757177414558673. Epub 2015 Jan 5.
10
Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.奇异变形杆菌临床分离株中blaOXA - 58碳青霉烯酶基因的染色体扩增
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01697-16. Print 2017 Feb.